Spectral Diagnostics Inc. (OTCMKTS:EDTXF) Stock Short Interest Falls 39.6%

Spectral Diagnostics Inc. (OTCMKTS:EDTXF) was the recipient of a significant decrease in short interest during the month of September. As of September 15th, there was short interest totaling 7,906 shares, a decrease of 39.6% from the August 31st total of 13,085 shares. Based on an average daily volume of 14,380 shares, the short-interest ratio is currently 0.5 days. Currently, 0.0% of the shares of the stock are short sold.

Spectral Diagnostics Stock Performance

EDTXF stock opened at $0.83 on Wednesday. Spectral Diagnostics has a 52-week low of $0.65 and a 52-week high of $1.15. The company has a market capitalization of $244.55 million, a P/E ratio of -8.30 and a beta of 0.16. The company has a fifty day moving average price of $0.94 and a 200-day moving average price of $0.97.

Spectral Diagnostics Company Profile

Spectral Diagnostics, now known as Spectral Medical Inc, is a Canadian medical-device and biotechnology company focused on products for the diagnosis and treatment of sepsis and septic shock. The company’s work centers on identifying endotoxemia, a condition in which bacterial endotoxins enter the bloodstream and can contribute to severe systemic inflammation.

Spectral’s primary diagnostic product is the Endotoxin Activity Assay (EAA), a blood test designed to measure a patient’s endotoxin activity and help identify individuals who may be at increased risk of developing severe sepsis.